Skip to main navigation Skip to search Skip to main content

Clinical and cardiac structural predictors of atrial fibrillation persistence

  • Aditya Bhat
  • , Henry H. L. Chen
  • , Shaun Khanna
  • , Gary C. H. Gan
  • , Walter P. Abhayaratna
  • , Maria Carmo P. Nunes
  • , Chandini Raina MacIntyre
  • , Timothy C. Tan

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

Aims: The persistence of atrial fibrillation (AF) has been associated with differential clinical outcomes, with studies showing that persistent and permanent AF results in increased morbidity and mortality when compared to the paroxysmal subtype. Given the established prognostic implications of AF subtype, we sought to discern the clinical and structural cardiac parameters associated with persistent/ permanent AF. Materials and methods: Consecutive patients admitted to our institution between January 2013 and January 2018 with a primary diagnosis of non-valvular AF who underwent comprehensive transthoracic echocardiography were retrospectively appraised. Assessment of clinical and echocardiographic parameters was undertaken and compared according to AF subtype. Results: Of 1010 patients, 665 (mean age 66.8 ± 13.5 years, 53% men) had comprehensive transthoracic echocardiography on index admission and were included in the primary analysis. The majority of patients (n = 468; 70%) had paroxysmal AF while 197 (30%) had persistent/ permanent AF. Multivariable logistic regression analysis showed that heart failure (adjusted OR 3.135; 95% CI 2.099 to 4.682, P <.001), right atrial (RA) area ≥18 cm2 (adjusted OR 2.147; 95% CI 1.413 to 3.261, P <.001) and left atrial emptying fraction (LAEF) ≤34% (adjusted OR 2.959; 95% CI 1.991 to 4.398, P <.001) were independent predictors of persistent /permanent AF. Conclusions: The presence of heart failure, increased RA size and impaired LA function were associated with persistent/ permanent AF. These clinical and cardiac structural risk markers of AF persistence may identify a target population for early intervention to prevent adverse cardiovascular outcomes.

Original languageEnglish
Article numbere13395
Number of pages8
JournalEuropean Journal of Clinical Investigation
Volume51
Issue number3
DOIs
Publication statusPublished - Mar 2021

Bibliographical note

Publisher Copyright:
© 2020 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Clinical and cardiac structural predictors of atrial fibrillation persistence'. Together they form a unique fingerprint.

Cite this